Analysis
Life sciences and health care M&A Update: Q1 2024
The escalating cost of labor and supplies, coupled with a growing number of high-acuity patients, is causing financial stress for hospitals.
Life sciences and health care trends
- Health care services
Generative AI solutions are being utilized to manage administrative tasks such as revenue cycle management, a trend that will continue in 2024.1
- Health care technology
The health care IT sector is experiencing heightened interest due to evolving consumer preferences and advancements in technology.2
- Life sciences and pharma services
Amid uncertainties in the capital markets, life sciences companies are working to ensure they are ready for IPOs and M&A transactions once market challenges abate.3
- Medical devices and supplies
The medical device industry is showing signs of optimism, with an upswing in the utilization of AI-powered digital treatments, at-home diagnostics, and a growing acceptance of biometric devices and wearables for remote patient monitoring.4
- Payors and payor services
The first quarter saw a significant rise in health insurance premiums, attributed to medical inflation, wage increases, and increase in costly treatments..5
This newsletter is a periodic compilation of certain capital markets information.
References
1 Roshan Deshmukh and Pooja Parvatkar, “5 key trends for Q1 2024 shaping the future, Allied Market Research, accessed May 2024.
2 Dan Linsalata and James Clark, “Healthcare IT sector brief Q1 2024,” Harris Williams, February 27, 2024.
3 Brad Burch et al., “Q1 activity shaping the outlook for 2024 in life sciences sector,” Stout, February 22, 2024.
4 Pride Industries, “Medical device industry trends for 2024,” January 5, 2024.
5 Alex Strautman, “Facing the future: Health insurance and health care 2024 trends,” Word & Brown, February 5, 2024.
Previous editions
- Life Sciences & Health Care M&A quarterly update: Q4 2023
- Life Sciences & Health Care M&A quarterly update: Q3 2023
- Life Sciences & Health Care M&A quarterly update: Q2 2023
- Life Sciences & Health Care M&A quarterly update: Q1 2023
- Life Sciences & Health Care M&A quarterly update: Q3 2022
- Life sciences and health care M&A update: Q2 2022
- Life sciences and health care M&A update: Q1 2022
- Life sciences and health care M&A update: Q4 2021
- Life sciences and health care M&A update: Q2 2021
- Life sciences and health care M&A update: Q1 2021
- Life sciences & health care M&A update: Q4 2020
- Life sciences & health care M&A update: Q2 2020
- Life sciences & health care M&A update: Q1 2020
- Life sciences & health care M&A update: Q4 2019
- Life sciences & health care M&A update: Q2 2019
- Life sciences & health care M&A update: Q1 2019
- Life sciences & health care M&A update: Q4 2018
- Life sciences & health care M&A update: Q3 2018
- Life sciences & health care M&A update: Q2 2018
- Life sciences & health care M&A update: Q1 2018
- Life sciences & health care M&A update: Q4 2017
- Life sciences & health care M&A update: Q3 2017
- Life sciences & health care M&A update: Q2 2017
- Life sciences & health care M&A update: Q4 2016